ECA Logo

In this section: 2013 Course

Course Outline

Swipe right on the table to view more...

Sunday,
Sept. 22 2013
Monday,
Sept. 23 2013
Tuesday,
Sept. 24 2013
Wednesday,
Sept. 25 2013
Thursday,
Sept. 26 2013
Friday,
Sept. 27 2013
  08:30–09:00
Programme introduction
Frank Nestle
Reinhard Angelmar
08:30–12:30
Valuation
Bill Magill
08:30–12:30
Commercialisation options
Paul Kewene-Hite
08:30–10:00
Pharmaceutical company – academia partnerships
Tom Tomayko
08:30–10:30
Business plan presentation preparation
Paul Kewene-Hite
  09:00–10:45
The bio-pharmaceutical industry and its environment
Reinhard Angelmar
    10:15–12:30
Biopharmaceutical company – academia deals
Olivier Goarnisson
10:30–12:30
Group presentations
Paul Kewene-Hite and other panel members
  11:00–12:30
The drug development process: from concept to CTA/IND
Brydon Bennett
      12:30
Conclusion
Reinhard Angelmar
  Lunch at INSEAD Restaurant Lunch at INSEAD Restaurant Lunch at INSEAD Restaurant Photo and Lunch at INSEAD Restaurant Packed lunch
  14:00–16:30
The drug development process (cont’d)
Brydon Bennett
14:00–16:15
What entrepreneurs in clinical academia should know about life science funding
Chandra B. Leo
14:00–18:00
Intellectual property
Wolfgang Weiss
13:30–15:00
Making the partnership work
Yves Doz
 
  16:45–18:00
How I became an academic biotech entrepreneur
Dario Neri
16:30–18:00
Technology evaluation at Harvard
Michal Preminger
  15:15–18:00
Essentials of business planning
Paul Kewene-Hite
 
19:30
Opening dinner and cocktails
Free evening 19:00
Cocktails at Danièle and Reinhard Angelmar’s home

Navigating the academic / commercial interface
Frank Nestle
19:00–20:00
On-campus dinner
19:30
Closing dinner at Le Château de Bourron Marlotte

Lessons of an academic entrepreneur
Carlo Pincelli
 
      20:00–22:00
Group work
Paul Kewene-Hite
   

Tuition fees, on-site accommodation and transport will be covered by FOCIS, thanks to an educational grant by Celgene.